IP Verse

Abbvie Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Abbvie Inc.

Patent Number:
EP3177645
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Applicant:
LINDHOFER, HORST, DR.
Opposition Date:
Nov 17, 2021
Patent Number:
EP3616720
Title:
Pharmaceutical Composition For Cancer Treatment
Applicant:
OSAKA UNIVERSITY
Opposition Date:
Nov 16, 2021
Patent Number:
EP3153526
Title:
Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity
Applicant:
INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Opposition Date:
Jun 21, 2021
Patent Number:
EP3219328
Title:
Human Anti-Il-23 Antibodies, Compositions, Method And Uses
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Mar 17, 2021
Patent Number:
EP2978446
Title:
Methods And Agents For Treating Alzheimer'S Disease
Applicant:
THE GENERAL HOSPITAL CORPORATION
Opposition Date:
Dec 4, 2020
Patent Number:
EP2780375
Title:
Binding Molecules For Bcma And Cd3
Applicant:
AMGEN INC.
Opposition Date:
Mar 6, 2020
Patent Number:
EP2654789
Title:
Antibodies Against Human Cd39 And Use Thereof
Applicant:
INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Opposition Date:
Feb 15, 2019
Patent Number:
EP2530091
Title:
Anti-Dll3 Antibody
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Jan 4, 2019

Latest patents of Abbvie Inc. opposed by its competitors

Patent:
EP2691134
Grant Date:
Oct 7, 2020
Title:
Improved Shroud Deployment In Automatic Injection Devices
Oppositions:
1
Patent:
EP3213750
Grant Date:
Aug 12, 2020
Title:
Combination Of Two Antivirals For Treating Hepatitis C
Oppositions:
1
Patent:
EP2897611
Grant Date:
Jul 24, 2019
Title:
Methods For Treating Hepatitis C
Oppositions:
1
Patent:
EP2968302
Grant Date:
Feb 13, 2019
Title:
Combination Of Direct Acting Antiviral Agents And Ribavirin For Treating Hcv Patients
Oppositions:
1
Patent:
EP2957307
Grant Date:
Jul 18, 2018
Title:
Automatic Injection Device
Oppositions:
1
Patent:
EP2258346
Grant Date:
Sep 27, 2017
Title:
Solid Pharmaceutical Dosage Form Comprising An Hiv Protease Inhibitor Solid Dispersion
Oppositions:
1
Patent:
EP2643322
Grant Date:
Aug 30, 2017
Title:
Salts And Crystalline Forms Of An Apoptosis-Inducing Agent
Oppositions:
1
Patent:
EP2506716
Grant Date:
May 17, 2017
Title:
Novel Tricyclic Compounds
Oppositions:
1
Patent:
EP2968301
Grant Date:
Apr 19, 2017
Title:
Combination Of Two Antivirals For Treating Hepatitis C
Oppositions:
1

Competitors of Abbvie Inc.

GENERICS (U.K.) LIMITED

HANSEPATENT PATENTANWALTE ANDRESEN SCHOLZ PARTG MBB

INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

Want to track Abbvie Inc.?

Feel free to send us a message here and we will get back to you